SCHEMBL20323754

SCHEMBL20323754

CCNCCCCCOc1cccc(OC2CCCCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP2D6 P10635 2/20 0.45
CYP1A2 P05177 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 2/20 0.44
PPARG P37231 4/20 0.43
TSHR P16473 2/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 1/20 0.40
HRH3 Q9Y5N1 2/20 0.39
DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20323891 0.87 KDM4E (0.46) ALDH1A1KDM4ETDP1CYP2D6KMT2A
Ethylene SCHEMBL27903211 0.76 ALDH1A1 (0.50) ALDH1A1KDM4ETDP1CYP2D6CYP1A2
SCHEMBL20128701 0.75 KDM4E (0.43) ALDH1A1KDM4ETDP1CYP2D6CYP1A2
SCHEMBL11663045 0.74 SLC6A4 (0.47) CYP2D6KMT2AMEN1
SCHEMBL24021874 0.73 ALDH1A1 (0.47) ALDH1A1KDM4ETDP1CYP2D6CYP1A2
SCHEMBL11895109 0.73 DRD2 (0.63) DRD2DRD4
SCHEMBL12250968 0.72 CYP2D6 (0.41) ALDH1A1KDM4ETDP1CYP2D6CYP1A2
SCHEMBL7616010 0.71 DRD2 (0.66) DRD2DRD4
SCHEMBL11466475 0.71 CHRNB4 (0.55) ALDH1A1CYP2D6MAPK1HRH3
SCHEMBL11447824 0.70 CHRNB4 (0.54) ALDH1A1CYP2D6MAPK1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018119448-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES Arvinas, Inc. (US) 2018-06-28 WO disclosed